Systematic review and meta‐analysis of triclosan‐coated sutures for the prevention of surgical‐site infection

Surgical‐site infections (SSIs) increase morbidity and mortality in surgical patients and represent an economic burden to healthcare systems. Experiments have shown that triclosan‐coated sutures (TCS) are beneficial in the prevention of SSI, although the results from individual randomized controlled trials (RCTs) are inconclusive. A meta‐analysis of available RCTs was performed to evaluate the efficacy of TCS in the prevention of SSI.

[1]  S. Rothenburger,et al.  In vivo and in vitro antibacterial efficacy of PDS plus (polidioxanone with triclosan) suture. , 2008, Surgical infections.

[2]  C. Edmiston,et al.  Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? , 2006, Journal of the American College of Surgeons.

[3]  L. López-Durán,et al.  Study of the efficacy of coated Vicryl plus antibacterial suture in an animal model of orthopedic surgery. , 2007, Surgical infections.

[4]  S. Dowd,et al.  Surgical site infections: biofilms, dehiscence and delayed healing , 2008 .

[5]  J. Alexander,et al.  Updated Recommendations for Control of Surgical Site Infections , 2011, Annals of surgery.

[6]  A. Hill,et al.  Triclosan-Impregnated Sutures to Decrease Surgical Site Infections: Systematic Review and Meta-Analysis of Randomized Trials , 2012, Annals of surgery.

[7]  S. Rothenburger,et al.  Experimental efficacy study of coated VICRYL plus antibacterial suture in guinea pigs challenged with Staphylococcus aureus. , 2004, Surgical infections.

[8]  R. Gaynes,et al.  Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[10]  D. Fry,et al.  The economic costs of surgical site infection. , 2002, Surgical infections.

[11]  P. Barie.  Surgical site infections: epidemiology and prevention. , 2002, Surgical infections.

[12]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[13]  E. Wolner,et al.  Triclosan-coated sutures for the reduction of sternal wound infections: economic considerations. , 2007, The Annals of thoracic surgery.

[14]  J E García-Sánchez,et al.  Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery. , 2007, The Journal of infection.

[15]  M. Schilling,et al.  Triclosan-coated sutures reduce wound infections after hepatobiliary surgery—a prospective non-randomized clinical pathway driven study , 2011, Langenbeck's Archives of Surgery.

[16]  W. Bojar,et al.  Triclosan−Coated Sutures in Oral Surgery , 2009 .

[17]  Õ. Horváth,et al.  Surgical site infections after abdominal closure in colorectal surgery using triclosan-coated absorbable suture (PDS Plus) vs. uncoated sutures (PDS II): a randomized multicenter study. , 2011, Surgical infections.

[18]  S. Fieuws,et al.  The effect of triclosan-coated sutures in wound healing. A double blind randomised prospective pilot study. , 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[19]  T. Tønnessen,et al.  Triclosan-coated sutures do not reduce leg wound infections after coronary artery bypass grafting. , 2012, Interactive cardiovascular and thoracic surgery.

[20]  I. Galal,et al.  Impact of using triclosan-antibacterial sutures on incidence of surgical site infection. , 2011, American journal of surgery.

[21]  W. Altemeier,et al.  Role of Suture Materials in the Development of Wound Infection , 1967, Annals of surgery.

[22]  Zhong-tao Zhang,et al.  Cosmetic outcome and surgical site infection rates of antibacterial absorbable (Polyglactin 910) suture compared to Chinese silk suture in breast cancer surgery: a randomized pilot research. , 2011, Chinese medical journal.

[23]  D Mirelman,et al.  Bacterial Adherence to Surgical Sutures: A Possible Factor in Suture Induced Infection , 1981, Annals of surgery.

[24]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[25]  M. Hawn,et al.  Surgical Site Infection Prevention: Time to Move Beyond the Surgical Care Improvement Program , 2011, Annals of surgery.

[26]  R. Darouiche,et al.  In vivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. , 1998, The Journal of heart valve disease.

[27]  Chatchai Mingmalairak,et al.  Efficacy of antimicrobial coating suture coated polyglactin 910 with tricosan (Vicryl plus) compared with polyglactin 910 (Vicryl) in reduced surgical site infection of appendicitis, double blind randomized control trial, preliminary safety report. , 2009, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[28]  S. Rothenburger,et al.  Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan , 2011, International wound journal.

[29]  A. Boccaccini,et al.  Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. , 2004, Biomaterials.

[30]  T. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. , 1999, American journal of infection control.

[31]  S. Rothenburger,et al.  In vitro antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). , 2007, Surgical infections.

[32]  H. Ford,et al.  Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). , 2005, Surgical infections.

[33]  T. Barbolt.  Chemistry and safety of triclosan, and its use as an antimicrobial coating on Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan). , 2002, Surgical infections.

[34]  Mark Storch,et al.  Physical and functional comparison of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) with Coated VICRYL* Suture (coated polyglactin 910 suture). , 2002, Surgical infections.

[35]  S. Rothenburger,et al.  In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. , 2002, Surgical infections.

[36]  Anne Berger,et al.  Surgical site infection – a European perspective of incidence and economic burden , 2004, International wound journal.

[37]  L. Perry,et al.  A 28-day study of the effect of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 suture with triclosan) on wound healing in guinea pig linear incisional skin wounds. , 2002, Surgical infections.

[38]  H. Sweetland,et al.  Randomized trial of antimicrobial-coated sutures to prevent surgical site infection after breast cancer surgery. , 2011, Surgical infections.

[39]  S. Rothenburger,et al.  In vivo antibacterial efficacy of MONOCRYL plus antibacterial suture (Poliglecaprone 25 with triclosan). , 2007, Surgical infections.

[40]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[41]  J. Costerton,et al.  Bacterial colonization of percutaneous sutures. , 1985, Surgery.

[42]  T. Horan,et al.  Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.

[43]  T. Chalmers,et al.  Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.

[44]  W J Martone,et al.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. , 1992, American journal of infection control.

[45]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[46]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[47]  J. Wenke,et al.  Bacterial adherence to suture materials. , 2011, Journal of surgical education.

[48]  D. Şelimen,et al.  Efficiency of antibacterial suture material in cardiac surgery: a double-blind randomized prospective study. , 2012, The heart surgery forum.

[49]  D. Pittet,et al.  Preventing surgical site infections , 2010, Expert review of anti-infective therapy.

[50]  M. Venermo,et al.  Effect of Triclosan-Coated Sutures on the Incidence of Surgical Wound Infection After Lower Limb Revascularization Surgery: A Randomized Controlled Trial , 2012, World Journal of Surgery.

[51]  C. Rozzelle,et al.  Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. , 2008, Journal of neurosurgery. Pediatrics.

[52]  V. Adam,et al.  Efficacy of antimicrobial triclosan-coated polyglactin 910 (Vicryl* Plus) suture for closure of the abdominal wall after colorectal surgery. , 2011, Collegium antropologicum.